FSD Pharma Strengthens Drug Development With GW Executive

TL;DR

FST Farmers is a cannabis company focused on building a hydroponic grow facility for medicinal cannabis and has made strategic investments in clinical trials and a platform company for future drug development.

Transcript

this is Gabriel with the investing news network I'm here today speaking with FST farmers management team at the bio tech showcase in San Francisco I'm speaking with the executive co-chairman Raza Bukhari and the CEO Rupert Haines thank you both for being here today so we wanted to get started off with the company is very focused on cannabis however... Read More

Key Insights

• 💗 FST Farmers is building a massive indoor hydroponic grow facility to meet the growing demand for medicinal cannabis.
• 🧑‍⚕️ The company has made strategic investments in clinical trials to explore the therapeutic potential of cannabinoids in gastrointestinal and cardiovascular health.
• 👨‍🔬 FST Farmers aims to expand its portfolio by investing in a platform company for synthetic cannabinoid research and drug development.
• 🤩 Purity and standardization are key concerns in the cannabis industry, and FST Farmers addresses these through its differentiated extraction technology and GNP-standardized processes.
• 😫 The company's focus on medicinal cannabis and potential international markets sets it apart from other cannabis companies.
• 🧘 FST Farmers' strong financial position and revenue projections for 2019 position the company favorably in the cannabis industry.
• 🪛 Consumer awareness and demand for purified and differentiated cannabis products will drive the industry's future growth.

Questions & Answers

Q: Can you provide an overview of FST Farmers' current focus and strategic investments?

FST Farmers is building a large hydroponic grow facility for medicinal cannabis and has invested in clinical trials exploring the role of cannabinoids in GI tract disorders and cardiovascular health. The company also plans to invest in a platform company for synthetic cannabinoid research and drug development.

Q: How is FST Farmers financing its operations and potential investments?

FST Farmers has been fortunate to have supportive investors who have seen remarkable returns. The company went public in 2018 and raised $53 million. They are considering a private investment in public equity (PIPE) to fund their strategic investment into a platform company.

Q: How does FST Farmers ensure the purity of its extraction process?

FST Farmers uses a differentiated technology for extraction and has invested in a world-class extraction company. They believe their extraction process for CBD is of high quality. Additionally, the company plans to utilize synthetic cannabinoids for pharmaceutical purposes to ensure standardized purity.

Q: How does FST Farmers differentiate itself from other cannabis companies in terms of growing and standardization processes?

FST Farmers focuses on the medicinal cannabis space and aims to become a supplier to not only Canada but also 20 other European countries and potential markets in the Far East. The company follows GNP standards for indoor facilities and works with state-of-the-art lighting and standardized processes to ensure high yields and product quality.

Summary & Key Takeaways

• FST Farmers is building the world's largest indoor hydroponic grow facility for medicinal cannabis in Coburg, outside Toronto, Canada.

• The company has made strategic investments, including funding clinical trials on the role of cannabinoids in gastrointestinal and cardiovascular health.

• FST Farmers aims to expand its portfolio by investing in a platform company focused on synthetic cannabinoid research and FDA-approved trials.